Zacks Small Cap Research on MSN
FBLG: Analyst Day Provides In-Depth Overview of Pipeline…
On February 12, 2025, Fibrobiologics, Inc. (NASDAQ:FBLG) held an Analyst Day and provided a comprehensive update on the ...
FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...
FibroBiologics, Inc. has announced its first quarter financial results for 2025, highlighting significant advances in its therapeutic development using fibroblast technology. The company completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback